KRISTIE WAGSTAFF: Open Payments
NPI 1548560519 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 4 | $73 |
| Exeltis, USA Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| CooperSurgical, Inc. | 1 | $23 |
| MILLICENT US INC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: NEXPLANON, SLYND, Veozah, INJECTAFER, ACCRUFER, Paragard T 380A, FEMRING, ABRYSVO.
Industry payments across VA — which companies pay providers there.
